Highlights
NASDAQ: EDIT       Editas Medicine
Last Price Today's Change   Day's Range   Trading Volume
27.87   +0.01 (0.04%)  27.30 - 27.94  96,741

Overview

 
Avg Volume (4 weeks):984,300
4 Weeks Range:21.41 - 31.28
4 Weeks Price Volatility (%):
65.45%
52 Weeks Range:14.01 - 34.37
52 Weeks Price Volatility (%):
68.07%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Editas Medicine Inc is a US-based genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company operates its business in a single segment of Developing and commercializing genome editing technology.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1984  3596  468  2903 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 JCP 0.1820.00 
 AVP 5.60-0.05 
 HTZ 1.13-0.18 
 AABA 19.630.00 
 TGE 22.39+0.81 
 HX 1.47+0.99 
 GE 7.147-0.143 
 ARPO 1.47+0.688 
 S 8.62+0.18 
 NIO 4.008-0.162 
Partners & Brokers